Litcius/Paper detail

Biomarkers of response to checkpoint inhibitors beyond PD-L1 in lung cancer

Lynette M. Sholl

2021Modern Pathology105 citationsDOI

Topics & Concepts

ImmunotherapyImmune checkpointLung cancerMedicineBiomarkerTumor microenvironmentCancerImmune systemCancer immunotherapyAntigenImmunologyCancer researchAntigen presentationT cellOncologyBiologyInternal medicineBiochemistryCancer Immunotherapy and BiomarkersLung Cancer Research StudiesPeptidase Inhibition and Analysis
Biomarkers of response to checkpoint inhibitors beyond PD-L1 in lung cancer | Litcius